On May 5, 2016, an application for authority to retain professionals was filed in the bankruptcy case of BIND Therapeutics, Inc. and its affiliates.
The filing was assigned docket number 52 and is described on the court’s official docket as follows:
Application/Motion to Employ/Retain Cowen and Company, LLC as Investment Banker to the Debtors Filed by BIND Therapeutics, Inc.. Hearing scheduled for 5/26/2016 at 09:00 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #1, Wilmington, Delaware. Objections due by 5/19/2016. (Attachments: # (1) Notice # (2) Exhibit A # (3) Exhibit B # (4) Exhibit C) (Steele, Amanda)
BIND Therapeutics, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on May 1, 2016. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 16-11084. The bankruptcy case is currently assigned to United States Bankruptcy Judge Judge Not Yet Assigned. The law firm of Latham & Watkins LLP is acting as lead bankruptcy counsel to BIND Therapeutics, Inc. in the bankruptcy case.